Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Keruakous, A.R.
25  Ergebnisse:
Personensuche X
?
1

Identifying Candidates for Effective Utilization of Stored ..:

Keruakous, Amany R. ; Walker, Laura ; Denlinger, Molly...
Hematology Reports.  16 (2024)  3 - p. 479-486 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Equity in oncology care: addressing disparities in cancer t..:

Keruakous, Amany R. ; Akpan, Inemesit ; Chahin, Michael..
Frontiers in Public Health.  12 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

Assessing Outcomes in Patients With Multiple Myeloma Postau..:

Brown, Zachary ; Scott, Campbell ; Zhang, Li Fang...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Barriers driving health care disparities in utilization of ..:

Keruakous, Amany R. ; Soror, Noha ; Jiménez, Sarah...
Frontiers in Public Health.  11 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

Barriers driving health care disparities in utilization of ..:

Amany R. Keruakous ; Noha Soror ; Sarah Jiménez...
https://www.frontiersin.org/articles/10.3389/fpubh.2023.1100466/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
6

Prognostic impact of natural killer cell recovery on minima..:

Keruakous, Amany R. ; Asch, Adam ; Aljumaily, Raid..
Transplant Immunology.  71 (2022)  - p. 101544 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Clinical Considerations for Immunoparesis in Multiple Myelo..:

Chahin, Michael ; Branham, Zachery ; Fox, Ashley..
Cancers.  14 (2022)  9 - p. 2278 , 2022
Link: https://doi.org/10.3390/..
 
?
8

Prognostic impact of natural killer cell recovery on minima..:

Keruakous, Amany R ; Asch, Adam ; Aljumaily, Raid..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434759/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Clinical Considerations for Immunoparesis in Multiple Myelo..:

Michael Chahin ; Zachery Branham ; Ashley Fox..
Cancer Immunology and Immunotherapy.  , 2022
Link: https://doi.org/10.3390/..
 
?
10

Clinical Considerations for Immunoparesis in Multiple Myelo..:

Michael Chahin ; Zachery Branham ; Ashley Fox..
https://www.mdpi.com/2072-6694/14/9/2278.  , 2022
Link: https://doi.org/10.3390/..
 
?
11

Disease biology alters the response to frontline bortezomib..:

Amany R, Keruakous ; Silas, Day ; Carrie, Yuen
Global Journal of Cancer Therapy.  , 2021
Link: https://doi.org/10.17352..
 
?
12

Research Staff Perspectives on Cancer Clinical Trials and B..:

Keruakous, Amany R ; Day, Silas ; Garcia-Ramiu, Kenny..
Cureus.  , 2021
Link: https://doi.org/10.7759/..
 
?
13

Azacitidine maintenance therapy post-allogeneic stem cell t..:

Keruakous, Amany R. ; Holter-Chakrabarty, Jennifer ; Schmidt, Sarah A....
Hematology/Oncology and Stem Cell Therapy.  , 2021
Link: https://doi.org/10.1016/..
 
?
14

Genomic profiling is a supplemental diagnostic and therapeu..:

Keruakous, Amany R. ; Balakrishna, Pragathi ; Schmidt, Sarah A...
Annals of Hematology.  100 (2021)  6 - p. 1629-1630 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Disease biology alters the response to frontline bortezomib..:

Amany R Keruakous ; Silas Day ; Carrie Yuen
https://doi.org/10.17352/2581-5407.000037.  , 2021
Link: https://doi.org/10.17352..
 
1-15